Hem › Ulcerös kolit › Utah
Kliniska studier för Ulcerös kolit i Utah
7 studier för Ulcerös kolit söker deltagare vid platser i Utah.
Städer i Utah
Officiell studietext (engelska)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Care Access-Ogden, Ogden
- Advanced Research Institute - South Ogden, Ogden
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06598943A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- University of Utah Hospitals & Clinics, Salt Lake City
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT06979336A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- University of Utah, Salt Lake City
RekryterarFas 3
Ålder 3 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06663332LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Care Access - Ogden, Ogden
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07186101A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Utah Health, Salt Lake City
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06095128An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Velocity Clinical Research, Salt Lake City - Site Number: 8400147, West Jordan
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 20 aug. 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Utah Health, Salt Lake City
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT05230173Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.